Literature DB >> 789826

Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.

C Solheid, G Lauro, G Palladini.   

Abstract

Sera from patients with malignant and benign gliomas, as well as sera from healthy donors, were tested by indirect immunofluorescence to detect antibodies against antigens on the membrane of glioblastoma, astrocytoma, reactive perimetastatic glia, normal glia and fibroblasts in tissue culture. Sera from glioblastoma patients reacted with glioblastoma, astrocytoma and reactive glial cells; they were negative on normal glia and on fibroblasts, whereas sera from astrocytoma patients were unreactive. Sera from control patients were positive in 7 out of 15 cases, although some differences were noted in the pattern of reaction. Absorption with astrocytoma powder, with glioblastoma and reactive glial cells indicated that all the positive cell lines expressed an astrocytoma-associated antigen "A", while only glioblastoma lines and reactive glial line shared a supplementary antigen "G". Neither of these 2 antigens seemed to be present in significant amount in normal brain, since the positive reactions could not be abolished by absorption with normal brain powder. The relationship between these 2 antigens and the process of increasing malignancy in gliomas is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789826     DOI: 10.1016/0022-510x(76)90255-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Induction of some features of glial differentiation in primary cultures of human gliomas by treatment with dibutyrl cyclic AMP.

Authors:  L W Haynes; R O Weller
Journal:  Br J Exp Pathol       Date:  1978-06

Review 2.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

3.  Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.

Authors:  G M Lauro; N Di Lorenzo; M Grossi; A Maleci; B Guidetti
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Authors:  M L Apuzzo; K M Sheikh; M H Weiss; J S Heiden; T Kurze
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

5.  Immunohistochemical demonstration of IgG in meningioma.

Authors:  K Tabuchi; Y Kawakami; A Nishimoto
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

6.  Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells.

Authors:  G M Lauro; C Solheid; L Medolago-Albani; N Di Lorenzo; B Guidetti
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.